Q3 2017

Filed Oct 31, 2017 · 10-Q · 31 days after period end · 0001193125-17-327138

Q3 2017 · 10-Q

Revenue

$0.00

— vs Q3 2016

Net Income

-$2.07M

N/M vs Q3 2016

EPS Diluted

-$0.42

N/M vs Q3 2016

Operating Income-$1,921,520N/M

Operating Cash Flow

Same quarter

Metric	Q3 2017	Q3 2016	Q3 2015	Q3 2014
Revenue	$0.00	$0.00	$329.80K	$201.01K
Net Income	-$2.07M	-$1.96M	-$1.86M	-$1.03M
EPS Diluted	-$0.42	-$0.04	-$0.05	-$0.03

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Oragenics Inc · CIK 1174940 · Engraved from SEC EDGAR